-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Jiangxi Provincial Drug Administration issued the "2021 No. 1 drug supervision and sampling information announcement" (hereinafter referred to as "announcement").
to strengthen drug quality supervision and ensure the safety of public drug use, drug regulatory departments and inspection agencies at all levels of the province have carried out supervision and sampling of drug production, operation and use units throughout the province, according to the
announcement.
verification confirmed that the current period of supervision and sampling found that 15 varieties of 18 batches do not meet the standard provisions, non-compliance with the provisions of the items including characteristics, inspection, content determination and so on.
combing found that in these 15 varieties of drugs, there are 8 kinds of preparations, respectively, vitamin C calcium capsules, psychic capsules, zinc sulfate tablets, cold heat particles, compound dansin tablets, compound wearing heart lotus tablets, octa-jinyi mother pills, aspirin intestinal solution tablets; according to the
announcement, the Jiangxi Provincial Drug Administration has tasked the relevant departments to take necessary control measures such as seizure, seizure, suspension of sales and recall of non-compliant drugs, and to investigate and punish the production enterprises and the sampled units in accordance with relevant laws and regulations.
。